BioVectra Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:BioVectra Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011843
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:15
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioVectra Inc (BioVectra), a subsidiary of Mallinckrodt Plc is a manufacturer and marketer of pharmaceutical ingredients. The company’s products include reducing reagents, bioprocessing reagents, molecular biology reagents, clinical diagnostic raw materials, high molecular weight vectra MPEG derivatives and neurochemicals. Its products are used for the treatment of cancer, kidney disease, multiple sclerosis, cardio-vascular disease, and other serious diseases. BioVectra also offers custom manufacturing services such as microbial and fungal fermentation, biomass extraction and purification, complex chemical manufacturing, methoxypolyethylene glycol functionalization, and high potency chemical processing. The company caters to pharmaceutical and biotechnology industries. It distributes its products through a network of distributors across Austria, Switzerland, Australia, Japan, France, Italy, Israel, the UK and the US. BioVectra is headquartered in Charlottetown, Prince Edward Island, Canada.

BioVectra Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioVectra Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
BioVectra Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
BioVectra Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
BioVectra Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
BioVectra Inc, Pharmaceuticals & Healthcare, Deal Details 9
Asset Purchase 9
Biovectra to Acquire Manufacturing Facility from Sepracor Canada 9
Partnerships 10
BioVectra Enters Into Co-Marketing Agreement With Quanta BioSciences 10
Acquisition 11
Questcor Pharma Completes Acquisition Of BioVectra, Contract Manufacturing Company, For US$101 Million 11
BioVectra Inc – Key Competitors 12
BioVectra Inc – Key Employees 13
BioVectra Inc – Locations And Subsidiaries 14
Head Office 14
Appendix 15
Methodology 15
About GlobalData 15
Contact Us 15
Disclaimer 15

List of Tables
BioVectra Inc, Pharmaceuticals & Healthcare, Key Facts 2
BioVectra Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
BioVectra Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
BioVectra Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
BioVectra Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
BioVectra Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Biovectra to Acquire Manufacturing Facility from Sepracor Canada 9
BioVectra Enters Into Co-Marketing Agreement With Quanta BioSciences 10
Questcor Pharma Completes Acquisition Of BioVectra, Contract Manufacturing Company, For US$101 Million 11
BioVectra Inc, Key Competitors 12
BioVectra Inc, Key Employees 13

★海外企業調査レポート[BioVectra Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • HDR, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' HDR, Inc. Mergers and Acquisiti …
  • Abionic SA:医療機器:M&Aディール及び事業提携情報
    Summary Abionic SA (Abionic) is a medical device company that develops, produces, and markets in vitro diagnostic devices. The company provides products such as abioSCOPE, IVD capsule, abioGUIDE, abioGUIDE application for android, iPhone and iPad, and accessories, among others. Its abioSCOPE in vitr …
  • Sinosteel Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Sinosteel Corporation Mergers a …
  • Comision Federal de Electricidad:企業の戦略的SWOT分析
    Comision Federal de Electricidad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • NovoCure Ltd (NVCR):企業財務及び戦略的SWOT分析
    Summary NovoCure Ltd (NovoCure) is an oncology company that focuses on the development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in various types of cancer indications such as ovarian cancer, malignant melanoma, hepatocellula …
  • Arcus SA (ARC):企業概要、財務及び戦略的SWOT分析
    Summary Arcus SA (Arcus) is an integrated systems supplier. The company offers documents management systems and mass correspondence management systems. It offers products such as documents management systems, correspondence management, ICT systems, smart control and smart grid. Arcus’s documents man …
  • Osage Exploration and Development, Inc. (OEDV)(石油・ガス分野):企業M&A動向
    Summary Osage Exploration and Development, Inc. (Osage) is an exploration and production company. The company operates oil and gas properties in the mid-continent region of the US. Its projects include Mississippi Lime and Woodford Shale. Osage identifies oil and gas properties and acquire those exp …
  • Weida (M) Berhad (WEIDA):企業概要、財務及び戦略的SWOT分析
    Summary Weida (M) Berhad (Weida) is an investment holding company. The company manufactures and sells engineering product and solutions. It offers water storage tanks, water LIPP tank systems, traffic equipment, marine products, custom-moulded products, and other environmental products. Weida’s acti …
  • Entergy Corporation (ETR):企業の財務及び戦略的SWOT分析
    Entergy Corporation (ETR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Lantronix, Inc. (LTRX):企業の財務・戦略的SWOT分析
    Lantronix, Inc. (LTRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Sequella, Inc.:(医療機器分野)企業M&A及び提携動向
    Summary Sequella, Inc. (Sequella) is a biopharmaceutical company. The company develops and commercializes products for diagnosis and treatment of infectious diseases. Its antibiotic pipeline includes tuberculosis, C.difficile infections and crohn’s disease. Sequella develop therapies for infections …
  • Pulse Utilities New Zealand Limited (PLE):企業の財務及び戦略的SWOT分析
    Summary Pulse Utilities New Zealand Limited (Pulse Energy) is an energy retailer that uses smart meter technology. The company’s smart meters enable customers to monitor their electricity usage and take advantage of discounted off peak rates. It replaces existing electricity meter with its smart met …
  • Golan Plastic Products Ltd. (GLPL):企業の財務及び戦略的SWOT分析
    Summary Golan Plastic Products Ltd. (Golan Plastic) is a plastic pipe manufacturer that develops and manufactures polyethylene pipe systems. The company’s products include PEX pipe, PEX pipe, pipe-in-pipe PEX-a and c, PE-RT pipes, EVOH coated pipes, MULTYGOL multilayer Al pipes, pre-insulated PEX pi …
  • PMP Limited (PMP):企業財務及び戦略的SWOT分析
    Summary PMP Limited (PMP) is a consumer insight and printed communications solutions provider that offers print and distribution service of catalogues, magazines and marketing materials. The company provides marketing services including print and distribution, data-driven marketing and customer anal …
  • Merck & Co Inc (MRK)-医療機器分野:企業M&A・提携分析
    Summary Merck & Co Inc (Merck) focuses on the discovery, development, manufacture and commercialization of prescription pharmaceuticals, biologic therapies, vaccines and animal healthcare products. It offers prescription products for treating cardiovascular, cancer, immunology, infectious, respirato …
  • Delta International Oil & Gas Inc (DLTZ):石油・ガス:M&Aディール及び事業提携情報
    Summary Delta International Oil & Gas Inc (Delta), formerly Delta Mutual Inc, is an oil and gas company. The company operates in the oil and gas acquisition and exploration activities. It also holds interests in oil and natural gas and development rights in Argentina. Delta’s oil and gas investments …
  • Hydro One Ltd (H):電力:M&Aディール及び事業提携情報
    Summary Hydro One Ltd (Hydro One) is a utility holding company that conducts electricity transmission and distribution in Ontario through its subsidiaries. It also undertakes telecommunications business and certain corporate activities. The company serves residential, commercial and industrial custo …
  • Venn Life Sciences Holdings Plc (VENN):企業のM&A・提携動向(医療分野)
    Summary Venn Life Sciences Holdings Plc (Venn Life Sciences), formerly Armscote Investment Company Plc is a contract research company that offers drug development and clinical services. The company’s drug development services comprise clinical development, drug candidate selection, in-licensing and …
  • Ileos SA:企業の戦略・SWOT・財務分析
    SummaryIleos SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - Det …
  • Basic Energy Corporation (BSC):企業の財務及び戦略的SWOT分析
    Summary Basic Energy Corporation (BEC) is a mineral exploration company that provides oil and gas exploration and development. The company provides exploration and production, and supply of alternative and renewable energy, oil and allied products. It operates oil and gas; geothermal energy and hydr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆